STAND. COM. REP. NO.  1051-12

 

Honolulu, Hawaii

                , 2012

 

RE:   S.B. No. 2228

      S.D. 2

      H.D. 1

 

 

 

 

Honorable Calvin K.Y. Say

Speaker, House of Representatives

Twenty-Sixth State Legislature

Regular Session of 2012

State of Hawaii

 

Sir:

 

     Your Committee on Health, to which was referred S.B. No. 2228, S.D. 2, entitled:

 

"A BILL FOR AN ACT RELATING TO PSEUDOEPHEDRINE,"

 

begs leave to report as follows:

 

     The purpose of this measure is to monitor the sale of products, mixtures, or preparations containing pseudoephedrine by:

 

(1)  Establishing an electronic tracking system for the sale of products containing pseudoephedrine base; and

 

(2)  Requiring the Department of Public Safety Narcotics Enforcement Division to implement the electronic tracking system.

 

     Legislative Information Services of Hawaii and Hawaii Food Industry Association testified in support of this measure.  The Department of Public Safety and the Department of the Attorney General testified in support of the intent of this measure.

 

     Your Committee has amended this measure by:

 

(1)  Specifying that the sales restriction applies to products, mixtures, or preparations that contain pseudoephedrine, not pseudoephedrine base;

 

(2)  Specifying that the record of sales of nonprescription products containing pseudoephedrine maintained by pharmacies or retailers shall be in written or electronic form; and

 

(3)  Making technical, nonsubstantive amendments for clarity, consistency, and style.

 

     As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2228, S.D. 2, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 2228, S.D. 2, H.D. 1, and be referred to the Committee on Judiciary.

 

Respectfully submitted on behalf of the members of the Committee on Health,

 

 

 

 

____________________________

RYAN I. YAMANE, Chair